Caribou Biosciences (CRBU) Revenue (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Revenue data on file, last reported at $2.4 million in Q1 2026.

• Revenue for Q1 2026 came in at $2.4 million, up 1.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.2 million (up 12.96% YoY), and the FY2025 annual result was $11.2 million, up 11.66% from the prior year.
• Revenue slipped to $2.4 million in Q1 2026 per CRBU's latest filing, from $3.9 million in the prior quarter.
• Over five years, Revenue peaked at $23.7 million in Q3 2023 and troughed at $2.0 million in Q3 2024.
• A 5-year average of $4.2 million and a median of $3.3 million in 2022 frame the typical range for Revenue.
• The sharpest annual moves came in 2023 and 2024: Revenue jumped 616.38% in 2023, then tumbled 91.45% in 2024.
• A 5-year view of Revenue shows it stood at $3.7 million in 2022, then retreated by 3.63% to $3.6 million in 2023, then tumbled by 41.62% to $2.1 million in 2024, then jumped by 89.74% to $3.9 million in 2025, then sank by 39.18% to $2.4 million in 2026.
• Business Quant data shows CRBU's Revenue at $2.4 million in Q1 2026, $3.9 million in Q4 2025, and $2.2 million in Q3 2025.